Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chinh Tran To Su

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioscience Reports|January 12, 2019
Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discoverySer-Xian Phua, Kwok-Fong Chan, Chinh Tran-To Su, et al.
Scientific Reports|June 21, 2017
The role of Antibody Vκ Framework 3 region towards Antigen binding: Effects on recombinant production and Protein L bindingChinh Tran-To Su, Wei-Li Ling, Wai-Heng Lua, et al.
BMC Bioinformatics|February 4, 2017
Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistanceChinh Tran-To Su, Wei-Li Ling, Wai-Heng Lua, et al.
Frontiers in Immunology|July 26, 2021
Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody SuperantigenChinh Tran-To Su, Wai-Heng Lua, Jun-Jie Poh, et al.
Frontiers in Immunology|December 28, 2020
Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab VariantsWei-Li Ling, Chinh Tran-To Su, Wai-Heng Lua, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2019
Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapyWai-Heng Lua, Chinh Tran-To Su, Joshua Yi Yeo, et al.
Cell Cycle (Georgetown, Tex.)|January 20, 2017
Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make itWai-Heng Lua, Wei-Li Ling, Chinh Tran-To Su, et al.
Molecules (Basel, Switzerland)|December 16, 2020
An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 SubunitKwok-Fong Chan, Chinh Tran-To Su, Alexander Krah, et al.
Scientific Reports|April 21, 2022
Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and LWei-Li Ling, Chinh Tran-To Su, Wai-Heng Lua, et al.
Bioinformatics Advances|December 16, 2024
epiTCR-KDA: knowledge distillation model on dihedral angles for TCR-peptide predictionMy-Diem Nguyen Pham, Chinh Tran-To Su, Thanh-Nhan Nguyen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioscience Reports|January 12, 2019
Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discoverySer-Xian Phua, Kwok-Fong Chan, Chinh Tran-To Su, et al.
Scientific Reports|June 21, 2017
The role of Antibody Vκ Framework 3 region towards Antigen binding: Effects on recombinant production and Protein L bindingChinh Tran-To Su, Wei-Li Ling, Wai-Heng Lua, et al.
BMC Bioinformatics|February 4, 2017
Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistanceChinh Tran-To Su, Wei-Li Ling, Wai-Heng Lua, et al.
Frontiers in Immunology|July 26, 2021
Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody SuperantigenChinh Tran-To Su, Wai-Heng Lua, Jun-Jie Poh, et al.
Frontiers in Immunology|December 28, 2020
Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab VariantsWei-Li Ling, Chinh Tran-To Su, Wai-Heng Lua, et al.
The Journal of Allergy and Clinical Immunology|April 18, 2019
Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapyWai-Heng Lua, Chinh Tran-To Su, Joshua Yi Yeo, et al.
Cell Cycle (Georgetown, Tex.)|January 20, 2017
Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make itWai-Heng Lua, Wei-Li Ling, Chinh Tran-To Su, et al.
Molecules (Basel, Switzerland)|December 16, 2020
An Alternative HIV-1 Non-Nucleoside Reverse Transcriptase Inhibition Mechanism: Targeting the p51 SubunitKwok-Fong Chan, Chinh Tran-To Su, Alexander Krah, et al.
Scientific Reports|April 21, 2022
Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and LWei-Li Ling, Chinh Tran-To Su, Wai-Heng Lua, et al.
Bioinformatics Advances|December 16, 2024
epiTCR-KDA: knowledge distillation model on dihedral angles for TCR-peptide predictionMy-Diem Nguyen Pham, Chinh Tran-To Su, Thanh-Nhan Nguyen, et al.
Pageof 3